MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Olfactory dysfunction"

  • MDS Virtual Congress 2021

    Smell dysfunction correlates with severity of motor deficits in H&Y stage-I early onset Parkinson’s disease

    J. Wang, R. Stanford, Q. Yang, L. Spreen, M. Wang, B. Mullen, K. Venkiteswaran, T. Subramanian (Hershey, USA)

    Objective: The objective of this study is to test the hypotheses that: 1) olfactory dysfunction in early stage Parkinson’s disease (PD) is correlated with severity…
  • MDS Virtual Congress 2021

    Extending the spectrum of non-motor symptoms in pre-motor Huntington’s disease – a pilot study

    B. Heim, D. Valent, F. Carbone, S. Spielberger, F. Krismer, A. Djamshidian, K. Seppi (Innsbruck, Austria)

    Objective: The aim of this pilot study was to investigate change of olfactory functions in Huntington's disease. Background: Huntington's disease (HD) is a neurodegenerative disease…
  • MDS Virtual Congress 2021

    Defining LRRK2-PD subsets based on olfactory function in the PPMI

    K. Marek, A. Siderowf, C. Tanner, T. Simuni, L. Chahine, M. Brumm, C. Coffey (New Haven, USA)

    Objective: A major goal of the Parkinson Progression Marker Initiative (PPMI) is to identify clinical and biomarker defined disease subsets that may demonstrate differing disease…
  • MDS Virtual Congress 2021

    Serum uric acid as a putative biomarker in Prodromal Parkinson’s disease: Longitudinal data from the PPMI study.

    C. Koros, A-M. Simitsi, N. Papagiannakis, A. Bougea, A. Prentakis, D. Papadimitriou, I. Pachi, R. Antonelou, E. Angelopoulou, E. Efthymiopoulou, I. Beratis, M. Bozi, S. Papageorgiou, A. Bonakis, M. Stamelou, L. Stefanis (Athens, Greece)

    Objective: Our present study assessed the role of serum uric acid as a putative biomarker in a prodromal PD cohort [REM Sleep Behavior disorder (RBD)…
  • MDS Virtual Congress 2021

    Comparisons Between Parkinson’s Disease Patients and At-Risk Individuals: Can Olfactory Deficits and Cognitive Measures Serve as Preclinical Markers?

    L. Pimer, J. Fisk, M. Khan, R. Mckelvey, H. Robertson, T. Rolheiser, K. Schoffer, K. Good (Halifax, Canada)

    Objective: To examine whether individuals at increased risk of developing Parkinson’s disease (PD) show specific cognitive impairments suggestive of progression towards PD. Background: Olfactory deficits…
  • MDS Virtual Congress 2021

    Serial DaT-SPECT imaging in asymptomatic carriers of LRRK2 G2019S mutation: 8-years follow-up

    A. Sánchez Rodríguez, I. Martínez Rodríguez, M. Sierra, P. Sánchez Juan, I. González Aramburu, M. Rivera Sánchez, J. Andrés Pacheco, A. Gutiérrez-González, O. Cuenca-Vera, J. Madera, A. García-Hernández, J. Infante (Santander, Spain)

    Objective: To characterize the 8-year progression of clinical and imaging biomarkers in a cohort of asymptomatic LRRK2 G2019S carriers and to assess its utility as predictors of…
  • MDS Virtual Congress 2021

    BASELINE OLFACTION TESTING IN PARKINSON’S DISEASE PATIENTS IS CORRELATED WITH LONG-TERM DOPAMINERGIC DENERVATION IN STRIATAL SUB-REGIONS: LONGITUDINAL DATA FROM THE PPMI STUDY.

    C. Koros, A-M. Simitsi, N. Papagiannakis, A. Prentakis, A. Bougea, D. Papadimitriou, R. Antonelou, I. Pachi, E. Angelopoulou, E. Stanitsa, I. Beratis, S. Papageorgiou, M. Stamelou, X. Trapali, L. Stefanis (Athens, Greece)

    Objective: The aim of the current study was to determine whether there are longitudinal differences in dopaminergic denervation of striatal sub-regions [signal reduction in 123I-FP-CIT…
  • MDS Virtual Congress 2021

    Relationship Between Hyposmia and Olfactory Network Connectivity in Patients With Parkinson’s Disease

    L. Pesantez Pacheco, S. Horovitz (Bethesda, USA)

    Objective: To examine resting-state functional Magnetic Resonance Imaging in a group of Parkinson’s Disease patients, used to characterize changes in functional connectivity of the olfactory…
  • MDS Virtual Congress 2021

    Predictive value of UPSIT subsets in prodromal Parkinson disease

    P. Vaswani, J. Morley, D. Jennings, A. Siderowf, K. Marek, P. Investigators (Philadelphia, USA)

    Objective: To assess the predictive value of previously published subsets of the University of Pennsylvania Smell Identification Test (UPSIT) odors for conversion to Parkinson disease…
  • MDS Virtual Congress 2020

    The role of dopamine mis-metabolism in preclinical Parkinson’s disease olfactory deficits

    L. Beauchamp, L. Vella, A. Bush, K. Barnham (Melbourne, Australia)

    Objective: To gain an understanding of the underlying pathological mechanisms of Parkinson’s disease (PD)-related hyposmia using post-mortem human olfactory bulbs and an in vivo model…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 14
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Kratom withdrawal induced orobuccal dyskinesia
  • Welcome to the MDS Abstracts Site
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley